Real-life experience of using pegylated liposomal doxorubicin in primary cutaneous T-cell lymphomas. Falkenhain-Lopez D, Puerta-Pena M, Fulgencio-Barbarin J, Sanchez-Velazquez A, et al. Clin Exp Dermatol 2022 Apr 15. doi: 10.1111/ced.15224.

Read + Share

Amedeo Smart

Independent Medical Education

Falkenhain-Lopez D, Puerta-Pena M, Fulgencio-Barbarin J, Sanchez-Velazquez A, et al. Real-life experience of using pegylated liposomal doxorubicin in primary cutaneous T-cell lymphomas. Clin Exp Dermatol 2022 Apr 15. doi: 10.1111/ced.15224.
PMID: 35426448